 Coronary recanalization rate intravenous bolus alteplase acute myocardial infarction demonstration animals tissue-type plasminogen activator prolonged thrombolysis clearance circulation pilot studies bolus administration patients Alteplase dose mg recanalization rate previous pilot study bolus doses mg alteplase patients acute myocardial infarction aim present trial efficacy safety bolus dose number patients objective angiographic reocclusion rate hours patients infarct-related coronary artery minutes time bolus dose infusion hours mg alteplase Sixty patients acute myocardial infarction documented total occlusion infarct-related coronary artery thrombolysis hours onset symptoms intravenous bolus dose alteplase mg body weight equal kg patient IU heparin mg aspirin mouth administration alteplase Coronary angiography minutes alteplase administration recanalization rate infarct-related coronary artery confidence interval minutes confidence interval minutes Pretreatment levels lipoprotein recanalization